# Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.

> **NCT01932060** · PHASE3 · COMPLETED · sponsor: **Stanford University** · enrollment: 51 (actual)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Oxytocin Infusion

## Key facts

- **NCT ID:** NCT01932060
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932060, "Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01932060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*